A significant proportion of early childhood wheezing appears not to be
due to atopy-induced pulmonary inflammation, and mediator studies in
atopic adults and older children may not be relevant to this age group
. The usefulness of inflammatory markers in young children is related
to 1) whether atopic: and nonatopic wheezing are associated with diffe
rent patterns of pulmonary inflammation, and 2) whether indirect measu
rements truly reflect the inflammatory milieu within the lung. Both as
sumptions remain unproved. Bronchoalveolar lavage (BAL) directly sampl
es the alveolar milieu and is a potential tool for defining both the p
ulmonary mediator profile, and to validate plasma mediator concentrati
ons. BAL fluid (BALF) eosinophil cationic protein (ECP) concentrations
accurately reflect pulmonary eosinophil activation, and the BALF inte
rleukin-2 to interleukin-4 ratio may be helpful in defining those chil
dren with established pulmonary sensitization to allergen. Of the medi
ators that have been measured in the plasma, ECP eosinophil protein X
(EPX) and major basic protein (MBP) correlate well with atopy-induced
wheezing. However atopic activation in other sites may also increase t
he plasma concentrations of eosinophil-specific mediators. The profile
of adhesion molecules in the plasma (e.g. soluble intercellular adhes
ion molecule-1, soluble vascular cell adhesion molecule-1 and E-select
ion) reflects transmigration of specific types of leucocytes across th
e pulmonary endothelium. To date, the potential of this group of solub
le markers to define the nature of pulmonary inflammation is unclear.
More information is therefore required on pulmonary inflammation in ea
rly childhood to guide the future use of plasma markers.